
æ¿ä»€æ¹æ£ã«ããé·åŽå€§åŠã§ãšãã©ãŠã€ã«ã¹ç ç©¶ãå¯èœã«ïŒãããã³ã¡ç· ãåãéè¿ïŒ12/14 23æ59åïŒ
ãšãã©ãŠã€ã«ã¹ãªã©èŽæ»çã®é«ãç åäœã䜿ã£ãå®éšãããããã«ãé·åŽå€§åŠã皌åãç®æããã€ãªã»ãŒããã£ãŒã¬ãã«ïŒBSLïŒ4æœèšã«ã€ããŠã審æ»ããŠããååŽçããåæ Œãã®å€æãããŸãããå¿ èŠãªæ¿ä»€ãæ¹æ£ããŠååŽçžãæå®ãããšãæãå±éºãªç åäœãç ç©¶ç®çã§æ±ããåœå åã®æœèšãäœå® å¯éå°ã§çšŒåããŠããŸããŸããçŠå³¶ã®åçºããå®å šããšèšãããŠããã®ã«ããæ³å®å€ãã®ããšãèµ·ããŸãããããã¯ãä»äººäºã§ã¯ãããŸãããæ¿ä»€ã®æ¹æ£åã«ãããã³ã¡ãåéããŠããŸãã12æ14æ¥23æ59åãŸã§ã«ããã²æèŠãéããŸãããïŒ
æ¿ä»€ã®æ¹æ£
ãšãã©ãŠã€ã«ã¹ãªã©ã¯ææçæ³ã§ã1çš®ç
åäœãã«èŠå®ãããŠãããææããã«ã¯ååŽçžããæå®ãããªããã°ãªããŸãããçŸè¡ã§ã¯ææè
ãåœãç¬ç«è¡æ¿æ³äººã«éå®ããŠããŸãããæ¿ä»€ãæ¹æ£ããŠé·åŽå€§åŠã远å ããããšããŠããŸãã12æ14æ¥23æ59åãŸã§åéããŠããã®ããããã«é¢ããæèŠã§ãã
â»äœæãæ°åã¯ä»»æã§ããæžããªããŠãæèŠã¯éããŸãã
ïŒïŒæ¹æ£ã®æŠèŠ
â ææçæ³æœè¡ä»€ã«ãææçæ³ç¬¬ 56 æ¡ã®ïŒç¬¬ïŒé ã®æ¿ä»€ã§å®ããæ³äººãšããŠæ°ãã«åœç«å€§åŠæ³äººé·åŽå€§åŠãå®ããã
æ¹æ£åã®ææçæ³ç¬¬ 56 æ¡ã®ïŒç¬¬ïŒé
ææçã®äºé²åã³ææçã®æ£è ã«å¯Ÿããå»çã«é¢ããæ³åŸïŒæïŒ


ïŒå¹³æå幎æ³åŸç¬¬ïŒïŒïŒå·ïŒ
é·åŽå€§åŠããšãã©ãŠã€ã«ã¹ãªã©ã®ãäžçš®ç åäœããææã§ããããã«ããã®éšåãæ¹æ£ãããšããããšã ãšæããŸãã
åé¡ç¹ã«ã€ããŠã¯ãè¹é²ç«ããã詳ããæžããŠãã ãã£ãŠããŸãã
è¿é£äœæ°ãæããèªã£ãåç»ãªã©ã玹ä»ããŠããã®ã§ãããã³ã¡ãæžãåã«ãã²ã芧ã«ãªã£ãŠãã ããã
é·åŽå€§åŠãšãšãã©åºè¡ç±ã®é¢ä¿
ãåœåã¯ç¬ç«è¡æ¿æ³äººãã«éå®ãããŠããã®ã«ããé·åŽå€§åŠããå ãããšããã®ã¯ãšãŠãåçªã«æããŸãããªãé·åŽå€§åŠãå ããããšã«ãªã£ãã®ãæ°ã«ãªã£ãã®ã§ãé·åŽå€§åŠã®ãã¬ã¹ãªãªãŒã¹ãªã©ãæãèµ·ãããŠã¿ãŸããã
2024 幎 9 æ30 æ¥ä»ã®ãªãªãŒã¹ã§ãé·åŽå€§åŠã¯ãã³ãã³å€§åŠè¡çã»ç±åž¯å»åŠå€§åŠé¢ïŒLSHTMïŒå åŠé·ã® Peter PiotïŒããŒã¿ãŒã»ããªããïŒå士ãžããé·åŽå€§åŠåèªå士ãã®ç§°å·ãæäžããããšã決å®ãããšçºè¡šããŸããã
Peter Piot å士ãžãé·åŽå€§åŠåèªå士ãã®ç§°å·ãæäžïŒ2024幎9æ30æ¥ïŒ
PeterPiot å士ã¯ã1976 幎ã¶ã€ãŒã«ã«ãŠãšãã©ãŠã€ã«ã¹ãå ±åçºèŠããããšã§äžççã«ç¥ãããŠããããã§ããé·åŽå€§åŠã§ã¯ç±åž¯å»åŠã»ã°ããŒãã«ãã«ã¹ç ç©¶ç§ïŒTMGHïŒã®éèŠãªé£æºæ©é¢ã®äžã€ãšããŠãPeterPiot å士ãåŠé·ãåãã LSHTM ãšç·å¯ãªé¢ä¿ãç¯ããŠãããšã®ããšã§ãããPeterPiot å士ã®çµæŽã§äžèšã®éšåãæ°ã«ãªããŸããã
Peter Piot å士ïŒ1949 幎çãŸãã»75 æ³ïŒã¯ããã«ã®ãŒåºèº«ãèšåºå»ã§ãããšãšãã«åŸ®çç©åŠè ã§ãããã1976 幎ã¶ã€ãŒã«ã«ãŠãšãã©ãŠã€ã«ã¹ãå ±åçºèŠããããšã§äžççã«ç¥ãããŠããŸãã1995 幎ãã 2008 幎ãŸã§åœé£ååãšã€ãºèšç»ïŒUNAIDSïŒå代äºåå±é·ãåœéé£åäºå次é·ãåããã»ããã¢ããªã«ã«ããã HIV/AIDSã女æ§ã®å¥åº·ãšææçã«é¢ããå é§çç ç©¶ãäž»å°ã欧米ãã¢ããªã«ã®ç ç©¶æ©é¢ã§æéããšãåãã2009 幎ã«ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã·ãã¢ãã§ããŒã«å°±ä»»ã
2009 幎ã«ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã·ãã¢ãã§ããŒã«å°±ä»»
ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã¯ããGaviã¯ã¯ãã³ã¢ã©ã€ã¢ã³ã¹ããã¯ã¯ãã³ã100æ¥ããã·ã§ã³ããæšãé²ãããCEPIãã«å€é¡ã®è³éæäŸãããŠããŸãã
ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ãšé·åŽå€§åŠãšã®é¢ä¿ãç¥ãããã«ãããã«æãèµ·ãããŸããã
2015幎11æ20æ¥
åã©ãã«å¯Ÿããèºççèã¯ã¯ãã³ã®å¹æã調æ»ããããã æ ç¹æŽ»çšãæ¥å¹Žãã宿œ
ç±åž¯å»åŠç ç©¶æã¯æ¥å¹Ž1æããçŽ12ååãæãããããã æ ç¹ã掻çšããŠéäžåœã«ãããåã©ãã察象ãšããèºççèã¯ã¯ãã³ã®å¹æã«ã€ããŠã®èª¿æ»ãè¡ããŸããããã¯ããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã®æ¯æŽãåããŠå®æœããããã®ã§ãéäžåœãªã©ã§ã®èºççèã«ããåã©ãã®ææïŒæ»äº¡ã®å€§å¹ ãªæå¶ãçã£ããã®ã§ããæ¥æ¬ã®å€§åŠãŸãã¯ç ç©¶æããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ããæ°çŸäžãã«ã®ç ç©¶è³éãç²åŸããã®ã¯ããããåããŠãšãªããŸãã
ãç ç©¶æéã
4幎ãç ç©¶éå§æ¥ïŒ2016幎1æ1æ¥ãç ç©¶çµäºæ¥ïŒ2019幎12æ31æ¥
ãè³éæäŸæ©é¢ã
ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£
è³éã¿ã€ãïŒã°ããŒãã«ãã«ã¹ãèºçãGlobal Health, Pneumonia
ç·è³éïŒ9,998,388ç±³ãã«(Project ID: OPP1139859)
ãæ¥æ¬ã®å€§åŠãŸãã¯ç ç©¶æããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ããæ°çŸäžãã«ã®ç ç©¶è³éãç²åŸããã®ã¯ããããåããŠãšãªããŸãããšã®ããšã§ããããããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ãšã®é¢ä¿ãæ·±ãŸã£ãŠãã£ãã®ãããããŸããã
ç±åž¯å»åŠç ç©¶æã¯ã1942幎ã«é·åŽå»ç§å€§åŠä»å±æ±äºé¢šåç ç ç©¶æãšããŠéèšããããã®åŸ1967幎ã«é·åŽå€§åŠé眮ç±åž¯å»åŠç ç©¶æãšãªã£ãããã§ãããç±åž¯ã»æ°èãŠã€ã«ã¹ææçç ç©¶ã«é¢ããWHOç ç©¶ååã»ã³ã¿ãŒããšããŠæå®ãåããŠåœè©²åéã§ã®åœéçãªååãè¡ã£ãŠãããWHOã®å«çã³ãŒã¹ã®éå¬ãWHO/GOARNã¡ã³ããŒãšããŠã°ããŒãã«ãªæ°èææç察å¿ãžã®ååãJICAåœéååäºæ¥ãç·æ¥æŽå©éãžã®åç»ãªã©ãéããŠè²¢ç®ããŠãããšã®ããšã
ãWHO/GOARNããšã¯ãâGlobal Outbreak Alert and Response Networkâã®ç¥ã§ããšãã©åºè¡ç±çã®åœéææçã®å±æ©çºçæã«äžçå±æã®ææç察çããŒã ãè¿ éã«æŽŸé£ã»éå¶ããåœéçãªæ çµã¿ãšããŠãäžçä¿å¥æ©é¢ïŒWHOïŒãå šäžçã®ããŒãããŒæ©é¢ã«ãã2000幎ã«èšç«ãããããã§ãã
é·åŽå€§åŠã¯WHOãé²ããããšããŠããããšã«è³åãããã®ã¡ã³ããŒã«å ¥ã£ãŠãããšããããšã®ããã§ã2023幎ã«ã¯äžèšã®ãªãªãŒã¹ãåºããŠããŸããã
G7 â»åŽä¿å¥âŒ€âŸäŒåã«åãã
é¡§ã¿ãããªãç±åž¯ç
ïŒNTDsïŒå¶å§ã«é¢ãã声æ
ãâ»åŽã¢ãŠãã«ã ã»ã¹ããŒãã¡ã³ãããçå®ïŒ2023幎5æ16æ¥ïŒ
â»åŽâŒ€åŠã®æ²³éèåŠâ»ã¯ãæ°åã³ãããŠã€ã«ã¹ææçã®ãã³ãããã¯å¯Ÿçã«å€ãã®è³æºãå²ããã察çãç ç©¶ãªã©ã⌀ããåŸéããé¡§ã¿ãããªãç±åž¯ç ïŒNTDsïŒã«å¯ŸããŠãäžçä¿å¥æ©é¢ïŒWHOïŒã«ããç·æ¥äºæ 宣âŸã®çµäºãçºè¡šããããã®ææã«ãNTDs 察çãšç ç©¶éçºã®å掻æ§åã®å¿ èŠæ§ãG7 è°â»åœã§ããâœæ¬ããçºä¿¡ã§ããæçŸ©ã¯âŒ€ãããšæããŸããâœæ¬ã代衚ããç±åž¯å»åŠç ç©¶æœèšãæã€æ¬åŠã¯ãåŠè¡çã®ã¿ãªãããç£å®åŠâº ãç¹ããäžçã® NTDs 察çã«è²¢ç®ããŠãŸãããŸãããšè¿°
ã¹ãŠããŸãã
é·åŽã¢ãŠãã«ã ã»ã¹ããŒãã¡ã³ããé¡§ã¿ãããªãç±åž¯ç ïŒNTDsïŒãã³ãã¥ããã£âŒåïŒé äžåïŒ
å ¬çç€Ÿå£æ³âŒã°ããŒãã«ãã«ã¹æè¡æ¯èåºâŸŠ(GHIT Fund)ãåœâœŽâŒ€åŠæ³âŒâ»åŽâŒ€åŠãUniting to Combat NTDsããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ãé¡§ã¿ãããªãç æ°ã®æ°è¬éçºã€ãã·ã¢ãã£ãïŒDNDiïŒãThe END FundãThe Global Health Innovation Alliance Accelerator (GHIAA)ãGlobal Institute for Disease Elimination (GLIDE)ãâœæ¬é¡§ã¿ãããªãç±åž¯ç ã¢ã©ã€ã¢ã³ã¹ ïŒJAGntd ïŒãâœæ¬è£œè¬âŒ¯æ¥åäŒïŒJPMA ïŒãMedicines Development for Global HealthãMerck KGaAãMSF Access Campaign (åœå¢ãªãå»åž«å£)ã〈å ✀ãã©ãžã«ã³ãã«ã»ã³ã³ãœãŒã·ã¢ã ãSDGsã»ãããã¹ã»ãžã£ãã³ïŒSPJïŒãäžçä¿å¥æ©é¢ïŒWHOïŒã°ããŒãã« NTD ããã°ã©ã åã³ã¢ããªã«å°åäºåæ(AFRO)ããã€ã©ãŒå»ç§âŒ€åŠãthe Special Programme for Research and Training in Tropical Diseases (TDR)ãåœé£éçºèšç»-ã¢ã¯ã»ã¹ïŒããªããªãŒããŒãããŒã·ãã
é·åŽå€§åŠé«åºŠææçç ç©¶ã»ã³ã¿ãŒé·ã¯ããã¬ãã§ããªãã¿ã®æ£®å 浩幞æ°ã§ãã
åœç«ææçç ç©¶æã®æå±±åºèïŒæ±äº¬éœæŠèµæå±±åžïŒ
æ¥æ¬ã«ã¯ããã§ã«ãšãã©ãŠã€ã«ã¹ãªã©ãããŠã¹ã«ææãããåç©å®éšãéå§ããæœèšããããŸãã
ãã®åã«ãé·åŽå€§åŠã®BSL-4ãããå Žæã確èªããŠãããŸãã

äœå®
å°ãæµŠäžæäŒãå°åŠæ ¡ãªã©ãããè¿ãã«ãããŸãã
ãã®ãèšçœ®ã®çµç·¯ãã®ããŒãžã«ã¯ãåœç«ææçç ç©¶æã®æå±±åºèã®ããšãæžãããŠããŸããã
äžæ¹ãæ¥æ¬ã§ã¯1981幎ã«ãåœç«ææçç ç©¶æã®æå±±åºèïŒæŠèµæå±±åžïŒã«ãBSL-4ç åäœã«å¯Ÿå¿ã§ããæœèšã建èšããŸããããäœæ°ã®äžã«å察ãããããšãèžãŸããBSL-4æœèšãšããŠã®äœ¿çšãèŠåãããŠããŸãããã2015幎8æææçæ³ã«åºã¥ããææçã®èšºæãäž»ãªç®çãšããŠãåçåŽåçããBSL-4æœèšïŒæ³ä»€çšèªã§ã¯ãç¹å®äžçš®ç åäœçæææœèšãïŒãšããŠæå®ãããçŸåšçšŒåããŠããŸãã
äžèšã®èšäºïŒ2024幎3æ27æ¥ä»ïŒã«ã¯ãããšãã©åºè¡ç±ã®åå ãšãªããšãã©ãŠã€ã«ã¹ãªã©ãããŠã¹ã«ææãããåç©å®éšãéå§ããããšæžãããŠããŸãã
æå±±åºèã¯ãåŠçœ®ãå¿ èŠãªææçæ£è ãçºçãããšãã«çšŒåãããšæã£ãŠããã®ã§ãããåç©å®éšãè¡ãããŠãããšã¯ç¥ããŸããã§ããã
äžèšã®èšäºã«ã¯ããæå±±åºèã¯æ£è ã®èšºæãæ²»çã«ç¹åããŠãããäºé²æ³ãæ²»çæ³ã®éçºç®çã®ç ç©¶ã¯ã§ããªãããšæžãããŠããã®ã§ãããæ²»çè¬ã®å¹æã確ãããããã®åç©å®éšã¯ããã®ã§ããããã
2020幎12æã®èšäºã«ã¯ããå»å¹Ž9æããšãã©åºè¡ç±ã®ãŠã€ã«ã¹ãéã³èŸŒãŸããæ€æ»æ³ã®ç²ŸåºŠã®æ€èšŒãªã©ãè¡ãããŠããŸãããšæžãããŠããŸããããã®æœèšãããæå±±åºèã®èæœåãææãããŠããããšãã©åºè¡ç±ã®ãŠã€ã«ã¹ã®æ¬å
¥ã«ããã£ãŠã¯ãåšèŸºäœæ°ã®å察ãªã©ããã£ããšæžãããŠããŸããããã«ãç§»è»¢ãæ€èšããŠãããšã®ããšã
å ±åæžã«ã¯ããŒïŒã®ç«å°æ¡ä»¶ïŒç§»è»¢å ïŒãæžãããŠããŸãã
â ïŒïŒæœèšã ããä»ã®æœèšãšé¢ãããšããã«äœçœ®ããªãããšã
â åçåŽåçãšè¿è·é¢ã§ããããšãå°ãªããšããçŸåšã®æå±±åºèãšååŽçãšã®è·é¢ïŒãããïŒïŒããã¡ãŒãã«ïŒãã倧ããé¢ãããããªããšããã£ãŠã¯ãªããªãã
â èªç¶çœå®³ã«ãã被害ãå°ãªãã§ããããšãæ±ããããã
â å°å ãšã®ååãªã³ãã¥ãã±ãŒã·ã§ã³ã«åºã¥ããå°åã®æ¹ã ã®çè§£ãåŸãå¿ èŠãããã
â ïŒïŒæœèšã®èšç»ãã建èšãæ¿èªãå°å äœæ°ã®çè§£ãåŸã皌åã«ã¯ãããïŒå¹ŽããïŒå¹Žä»¥äžã®ææ¥ãå¿ èŠãšäºæ³ãããã
â åœã®ææç察çã®åºç€ãæ ãææç ã«ïŒ¢ïŒ³ïŒ¬ïŒïŒæœèšãååšããªãäºæ ã¯ãçæéã§ãã£ããšããŠã絶察ã«é¿ããªããã°ãªããªãã
é·åŽã ããé¢ä¿ãªããæŠèµæå±±ã ããé¢ä¿ãªããšããããšã§ã¯ãããŸããããã¹ãŠã¯ãç§ãã¡ã®ç掻ã«é¢ä¿ããŠããããšã§ããç¡é¢å¿ã§ããŠã¯ããã®ãããªããšãã©ãã©ãåæã«æ±ºããããŠããŸããŸãã
ããšãå°ããªããšã§ããä»èªåã«ã§ããããšã¯äœãèããŠãã§ããããšããããŸãããïŒ
ããã³ã¡ã¯ã12æ14æ¥ïŒåïŒ23æ59åãŸã§ã§ãïŒïŒ